The past year has witnessed a worsening of the global TB pandemic. For example, in Eastern Europe, where drug-resistant TB has thrived since the Soviet era, Russia’s calamitous invasion is halting promising progress. An example in the field of new TB therapeutics is the demonstration that the treatment of highly drug-resistant forms of TB can be shortened from 18 months (or longer) to six months. When it comes to treating drug-resistant TB, India’s success rate is reported to be as low as 48 per cent. Everyone committed to ending TB must move faster to adopt new technologies that are shown to be safe and effective.

Source: The Hindu April 03, 2022 21:46 UTC